Ftc and doj host final listening session on lowering drug prices through competition

Webp 5pp2ko12vzx927qgsfze54lv4smd
Andrew N. Ferguson Chairman | Federal Trade Commission

Ftc and doj host final listening session on lowering drug prices through competition

ORGANIZATIONS IN THIS STORY

The Federal Trade Commission (FTC) and the Department of Justice’s Antitrust Division, together with the Department of Commerce and the Department of Health and Human Services, will hold the final session in a series focused on making prescription drugs more affordable through increased competition. The event is scheduled for Monday, August 4, 2025, at 2 p.m. Eastern Time.

This third listening session aims to discuss how to implement ideas from earlier meetings to help lower drug prices. Attendance in person is by invitation only, but the event will be available via online streaming.

Health care policy experts are expected to provide remarks during the session.

According to the FTC, "The Federal Trade Commission works to promote competition, and to protect and educate consumers. The FTC will never demand money, make threats, tell you to transfer money, or promise you a prize. You can learn more about how competition benefits consumers, file an antitrust complaint, or comment on a proposed merger. For the latest news and resources, follow the FTC on social media, subscribe to press releases, and read our blog."

ORGANIZATIONS IN THIS STORY